1. Academic Validation
  2. Efficient generation of human immune system rats using human CD34+ cells

Efficient generation of human immune system rats using human CD34+ cells

  • Stem Cell Reports. 2024 Sep 10;19(9):1255-1263. doi: 10.1016/j.stemcr.2024.07.005.
Séverine Ménoret 1 Florence Renart-Depontieu 2 Gaelle Martin 2 Kader Thiam 2 Ignacio Anegon 3
Affiliations

Affiliations

  • 1 Nantes Université, CHU Nantes, Inserm, CNRS, SFR Santé, Inserm UMS 016, CNRS UMS 3556, F-44000 Nantes, France; INSERM, Centre de Recherche en Transplantation et Immunologie UMR1064, Nantes Université, Nantes, France. Electronic address: severine.menoret@univ-nantes.fr.
  • 2 genOway, 69007 Lyon, France.
  • 3 INSERM, Centre de Recherche en Transplantation et Immunologie UMR1064, Nantes Université, Nantes, France. Electronic address: ianegon@nantes.inserm.fr.
Abstract

Human immune system (HIS) mice generated using human CD34+ hematopoietic stem cells serve as a pivotal model for the in vivo evaluation of immunotherapies for humans. Yet, HIS mice possess certain limitations. Rats, due to their size and comprehensive immune system, hold promise for translational experiments. Here, we describe an efficacious method for long-term immune humanization, through intrahepatic injection of hCD34+ cells in newborn immunodeficient rats expressing human SIRPα. In contrast to HIS mice and similar to humans, HIS rats showed in blood a predominance of T cells, followed by B cells. Immune humanization was also high in central and secondary lymphoid organs. HIS rats treated with the anti-human CD3 antibody were depleted of human T cells, and human cytokines were detected in sera. We describe for the first time a method to efficiently generate HIS rats. HIS rats have the potential to be a useful model for translational immunology.

Keywords

cancer models; human immune system mice; immunodeficient rodents; immunotherapy; regenerative medicine; transplantation.

Figures
Products